CDC news from FiercePharma
News
CDC backs wide use of Merck's Zostavax
SPOTLIGHT: CDC backs wide use of Merck's Zostavax
... Read more...ALSO NOTED: Novo Nordisk creating 400 NJ jobs; Schering to sell off animal products;
> GlaxoSmithKline is acquiring Cambridge, MA-based Sirtris Pharmaceuticals for $720 million. GSK will pay $22.50 per share for the company. Read more...
France picks Gardasil over GSK upstart
Gardasil captured more territory for Merck and Sanofi-Aventis yesterday when French health officials recommended that vaccine against Human Papilloma Virus, or HPV. The French authority recommended... Read more...
SPOTLIGHT: CDC halts Hib boosters after Merck recall
In the wake of Merck's Hib vaccine recall, the CDC is telling docs to stop giving the booster shot... Read more...
CDC: Plenty of flu vaccine to go around
You know flu season's coming up when the media starts chanting about flu vaccines and flu remedies. So break out the tissue and fluids, because three big flu stories hit the news today. First, good... Read more...
Get more CDC coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
